CRISPR Therapeutics AG (CRSP) Receivables (2015 - 2024)
CRISPR Therapeutics AG (CRSP) reported Receivables of $27.1 million for Q4 2024, down 86.88% on a YoY basis from $206.5 million in Q1 2024, and down 86.88% sequentially from $206.5 million in Q4 2023.
CRISPR Therapeutics AG (CRSP) Receivables (2015 - 2024) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 10 years of Receivables data on file, last reported at $27.1 million in Q4 2024.
- For the quarter ending Q4 2024, Receivables fell 86.88% year-over-year to $27.1 million; the trailing twelve-month figure through Dec 2024 stood at $27.1 million (down 86.88% YoY), and the FY2024 full-year result was $27.1 million, down 86.88% from the prior year.
- Receivables retreated to $27.1 million in Q4 2024, from $206.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $206.5 million in Q4 2023 to a low of $49000.0 in Q3 2022.
- A 5-year average of $29.0 million and a median of $10.8 million in 2020 frame the typical range for Receivables.
- Across the five-year window, Receivables plunged 99.7% in 2021 and jumped 105960.61% in 2023, its largest moves.
- Tracing CRSP's Receivables over 5 years: stood at $10.8 million in 2020, then retreated by 19.73% to $8.7 million in 2021, then gained by 28.66% to $11.2 million in 2022, then soared by 1743.75% to $206.5 million in 2023, then plunged by 86.88% to $27.1 million in 2024.
- Business Quant data shows CRSP's Receivables at $27.1 million in Q4 2024, $206.5 million in Q4 2023, and $70.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 27.10 Mn |
| Dec 31, 2023 | 206.50 Mn |
| Jun 30, 2023 | 70.00 Mn |
| Dec 31, 2022 | 11.20 Mn |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 143,000.00 |
| Dec 31, 2021 | 8.71 Mn |
| Sep 30, 2021 | 152,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 150,000.00 |
| Dec 31, 2020 | 10.84 Mn |
| Sep 30, 2020 | 25.11 Mn |
| Jun 30, 2020 | 25.03 Mn |
| Mar 31, 2020 | 50.12 Mn |
| Dec 31, 2019 | 29.80 Mn |
| Sep 30, 2019 | 27.20 Mn |
| Jun 30, 2019 | 3.12 Mn |
| Mar 31, 2019 | 4.33 Mn |
| Dec 31, 2018 | 3.49 Mn |